Joseph Miller
Board Member
Avalo Therapeutics, Inc. (AVTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-01-01–present
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Financial Officer | $526,988 | $2,102,747 |
| 2024 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Financial Officer | $500,701 | $2,297,805 |
| 2023 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Financial Officer | $500,701 | $3,976,937 |
| 2020 | Avalo Therapeutics, Inc. (AVTX) | Former Chief Financial Officer, former principal financial officer, and former principal executive officer | $116,748 | $232,269 |
| 2019 | Avalo Therapeutics, Inc. (AVTX) | Former Chief Financial Officer, former principal financial officer, and former principal executive officer | $356,000 | $1,170,598 |
| 2018 | Avalo Therapeutics, Inc. (AVTX) | Former Chief Financial Officer, former Principal Financial Officer, and former Principal Executive Officer | $153,600 | $672,985 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.